268 related articles for article (PubMed ID: 36342647)
1. Conservative axillary surgery is emerging in the surgical management of breast cancer.
Noguchi M; Inokuchi M; Yokoi-Noguchi M; Morioka E; Haba Y
Breast Cancer; 2023 Jan; 30(1):14-22. PubMed ID: 36342647
[TBL] [Abstract][Full Text] [Related]
2. Using the axillary reverse mapping technique to screen breast cancer patients with a high risk of lymphedema.
Liu S; Wang N; Gao P; Liu P; Yang H; Xie F; Wang S; Liu M; Wang S
World J Surg Oncol; 2020 Jun; 18(1):118. PubMed ID: 32482174
[TBL] [Abstract][Full Text] [Related]
3. Conservative Axillary Surgery May Prevent Arm Lymphedema without Increasing Axillary Recurrence in the Surgical Management of Breast Cancer.
Noguchi M; Inokuchi M; Yokoi-Noguchi M; Morioka E; Haba Y
Cancers (Basel); 2023 Nov; 15(22):. PubMed ID: 38001613
[TBL] [Abstract][Full Text] [Related]
4. Axillary surgery for breast cancer: past, present, and future.
Noguchi M; Inokuchi M; Noguchi M; Morioka E; Ohno Y; Kurita T
Breast Cancer; 2021 Jan; 28(1):9-15. PubMed ID: 33165758
[TBL] [Abstract][Full Text] [Related]
5. Minimize the extent and morbidity of axillary dissection for node-positive breast cancer patients: implementation of axillary lymph node dissection based on breast lymphatics level.
Yuan Q; Hou J; He Y; Liao Y; Zheng L; Wu G
BMC Cancer; 2021 Mar; 21(1):293. PubMed ID: 33740930
[TBL] [Abstract][Full Text] [Related]
6. The clinical relevance of axillary reverse mapping (ARM): study protocol for a randomized controlled trial.
Klompenhouwer EG; Gobardhan PD; Beek MA; Voogd AC; Luiten EJ
Trials; 2013 Apr; 14():111. PubMed ID: 23782712
[TBL] [Abstract][Full Text] [Related]
7. Axillary reverse mapping in patients undergoing axillary dissection -a short review of the literature.
Noguchi M; Inokuchi M; Noguchi M; Morioka E; Kurita T
Eur J Surg Oncol; 2020 Dec; 46(12):2218-2220. PubMed ID: 32912671
[TBL] [Abstract][Full Text] [Related]
8. A patient- and assessor-blinded randomized controlled trial of axillary reverse mapping (ARM) in patients with early breast cancer.
Beek MA; Gobardhan PD; Klompenhouwer EG; Menke-Pluijmers MB; Steenvoorde P; Merkus JW; Rutten HJ; Voogd AC; Luiten EJ
Eur J Surg Oncol; 2020 Jan; 46(1):59-64. PubMed ID: 31402072
[TBL] [Abstract][Full Text] [Related]
9. Management of the Axilla in T1-2 Breast Cancer Patients with Macrometastatic Sentinel Node Involvement Who Underwent Breast-Conserving Therapy.
Kuru B; Yuruker S; Sullu Y; Gursel B; Ozen N
J Invest Surg; 2019 Jan; 32(1):48-54. PubMed ID: 28945489
[TBL] [Abstract][Full Text] [Related]
10. Sentinel lymph node biopsy without axillary lymphadenectomy after neoadjuvant chemotherapy is accurate and safe for selected patients: the GANEA 2 study.
Classe JM; Loaec C; Gimbergues P; Alran S; de Lara CT; Dupre PF; Rouzier R; Faure C; Paillocher N; Chauvet MP; Houvenaeghel G; Gutowski M; De Blay P; Verhaeghe JL; Barranger E; Lefebvre C; Ngo C; Ferron G; Palpacuer C; Campion L
Breast Cancer Res Treat; 2019 Jan; 173(2):343-352. PubMed ID: 30343457
[TBL] [Abstract][Full Text] [Related]
11. Does Axillary Reverse Mapping Prevent Lymphedema After Lymphadenectomy?
Tummel E; Ochoa D; Korourian S; Betzold R; Adkins L; McCarthy M; Hung S; Kalkwarf K; Gallagher K; Lee JY; Klimberg VS
Ann Surg; 2017 May; 265(5):987-992. PubMed ID: 27163955
[TBL] [Abstract][Full Text] [Related]
12. Is axillary reverse mapping feasible in breast cancer patients?
Noguchi M; Miura S; Morioka E; Ohno Y; Yokoi-Noguchi M; Nakano Y; Kosaka T
Eur J Surg Oncol; 2015 Apr; 41(4):442-9. PubMed ID: 25704555
[TBL] [Abstract][Full Text] [Related]
13. The involvement of axillary reverse mapping nodes in patients with clinically node-negative breast cancer.
Noguchi M; Inokuchi M; Yokoi-Noguchi M; Morioka E
Breast Cancer; 2022 Mar; 29(2):209-215. PubMed ID: 34591289
[TBL] [Abstract][Full Text] [Related]
14. Changes in Surgical Management of the Axilla Over 11 Years - Report on More Than 1500 Breast Cancer Patients Treated with Neoadjuvant Chemotherapy on the Prospective I-SPY2 Trial.
Boughey JC; Yu H; Dugan CL; Piltin MA; Postlewait L; Son JD; Edmiston KK; Godellas CV; Lee MC; Carr MJ; Tonneson JE; Crown A; Lancaster RB; Woriax HE; Ewing CA; Chau HS; Patterson AK; Wong JM; Alvarado MD; Yang RL; Chan TW; Sheade JB; Ahrendt GM; Larson KE; Switalla K; Tuttle TM; Tchou JC; Rao R; Tamirisa N; Singh P; Gould RE; Terando A; Sauder C; Hewitt K; Chiba A; Esserman LJ; Mukhtar RA
Ann Surg Oncol; 2023 Oct; 30(11):6401-6410. PubMed ID: 37380911
[TBL] [Abstract][Full Text] [Related]
15. Sentinel lymph node biopsy after neoadjuvant chemotherapy in patients with node-positive breast cancer: guiding a more selective axillary approach.
Damin AP; Zancan M; Melo MP; Biazus JV
Breast Cancer Res Treat; 2021 Apr; 186(2):527-534. PubMed ID: 33165710
[TBL] [Abstract][Full Text] [Related]
16. [Identification and preservation of arm lymphatics in axillary lymph node dissection to prevent arm lymphedema: a single center randomized controlled trial].
Yuan QQ; Wu GS; Hou JX; Zheng LW; Liao YQ; He YK
Zhonghua Zhong Liu Za Zhi; 2022 May; 44(5):430-435. PubMed ID: 35615800
[No Abstract] [Full Text] [Related]
17. Axillary reverse mapping (ARM): where to go.
Shao X; Sun B; Shen Y
Breast Cancer; 2019 Jan; 26(1):1-10. PubMed ID: 29961238
[TBL] [Abstract][Full Text] [Related]
18. Axillary lymph node recurrence following wire-directed sentinel lymph node dissection for breast cancer patients with biopsy-proven axillary metastases prior to neoadjuvant chemotherapy at a safety net medical center.
Sargent RE; Siegel E; Ito F; Kramme K; Kraft E; Hendrix V; Carr AA; Nelson ME; Bian SX; Jayachandran P; Sener SF
J Surg Oncol; 2023 Jul; 128(1):9-15. PubMed ID: 36933187
[TBL] [Abstract][Full Text] [Related]
19. Axillary lymph node dissection vs. sentinel node biopsy for early-stage clinically node-negative breast cancer: a systematic review and meta-analysis.
Petousis S; Christidis P; Margioula-Siarkou C; Liberis A; Vavoulidis E; Margioula-Siarkou G; Vatopoulou A; Papanikolaou A; Mavromatidis G; Dinas K
Arch Gynecol Obstet; 2022 Oct; 306(4):1221-1234. PubMed ID: 35249123
[TBL] [Abstract][Full Text] [Related]
20. Efficacy and safety comparison between axillary lymph node dissection with no axillary surgery in patients with sentinel node-positive breast cancer: a systematic review and meta-analysis.
Fan YJ; Li JC; Zhu DM; Zhu HL; Zhao Y; Zhu XB; Wu G; Bai TT
BMC Surg; 2023 Jul; 23(1):209. PubMed ID: 37495945
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]